KELLI BAKER: Open Payments
NPI 1255880779 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 34 payments from 19 companies in 2025. Trend: 2023 $608 · 2024 $460 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Abbott Laboratories | 3 | $61 |
| Novo Nordisk Inc | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Radius Health, Inc. | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Corcept Therapeutics | 2 | $32 |
| Ascensia Diabetes Care Us Inc. | 2 | $30 |
Products named: LEQVIO, FREESTYLE LIBRE 3, GVOKE HYPOPEN, MOUNJARO, Tymlos, Ozempic, TWIIST, XIFAXAN.
Industry payments across OH — which companies pay providers there.
